Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species
- 1 April 2000
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 6 (4) , 195-201
- https://doi.org/10.1046/j.1469-0691.2000.00031.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Comparative in vitro activities of trovafloxacin (CP-99,219) against 221 aerobic and 217 anaerobic bacteria isolated from patients with intra-abdominal infectionsAntimicrobial Agents and Chemotherapy, 1997
- Possible Role for the New Fluoroquinolones (Levofloxacin, Grepafloxacin, Trovafloxacin, Clinafloxacin, Sparfloxacin, and DU-6859a) in the Treatment of Anaerobic Infections: Review of Current Information on Efficacy and SafetyClinical Infectious Diseases, 1996
- Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobesAntimicrobial Agents and Chemotherapy, 1994
- In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1993
- In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridoneAntimicrobial Agents and Chemotherapy, 1993
- Antibiotic disk diffusion testing revisited. Single strain regression analysisAPMIS, 1991
- Anaerobic susceptibility tests: differences between disc diffusion, agar dilution and broth microdilution test resultsJournal of Antimicrobial Chemotherapy, 1990
- Multilaboratory Evaluation of an Agar Diffusion Disk Susceptibility Test for Rapidly Growing Anaerobic BacteriaClinical Infectious Diseases, 1990
- Laboratory- and species-specific interpretive breakpoints for disk diffusion tests of chloramphenicol susceptibility of Haemophilus influenzaeAntimicrobial Agents and Chemotherapy, 1988
- Interpretation of agar diffusion testsJournal of Antimicrobial Chemotherapy, 1980